|
1
|
Clopidogrel versus aspirin and esomeprazole to prevent recurrent ulcer bleeding.
|
N Engl J Med
|
2005
|
6.39
|
|
2
|
Hepatitis B virus reactivation in lymphoma patients with prior resolved hepatitis B undergoing anticancer therapy with or without rituximab.
|
J Clin Oncol
|
2008
|
3.44
|
|
3
|
Sofosbuvir and Velpatasvir for HCV Genotype 1, 2, 4, 5, and 6 Infection.
|
N Engl J Med
|
2015
|
3.16
|
|
4
|
Eradication of Helicobacter pylori and risk of peptic ulcers in patients starting long-term treatment with non-steroidal anti-inflammatory drugs: a randomised trial.
|
Lancet
|
2002
|
2.52
|
|
5
|
Comparison of EUS and ERCP in the investigation with suspected biliary obstruction caused by choledocholithiasis: a randomized study.
|
Gastrointest Endosc
|
2007
|
2.50
|
|
6
|
Enteric involvement of severe acute respiratory syndrome-associated coronavirus infection.
|
Gastroenterology
|
2003
|
2.36
|
|
7
|
Noninvasive detection of cancer-associated genome-wide hypomethylation and copy number aberrations by plasma DNA bisulfite sequencing.
|
Proc Natl Acad Sci U S A
|
2013
|
2.05
|
|
8
|
Long-term outcome of Helicobacter pylori-negative idiopathic bleeding ulcers: a prospective cohort study.
|
Gastroenterology
|
2005
|
1.56
|
|
9
|
The anti-inflammatory effect of celecoxib does not prevent liver fibrosis in bile duct-ligated rats.
|
Liver Int
|
2008
|
1.43
|
|
10
|
On-treatment alpha-fetoprotein is a specific tumor marker for hepatocellular carcinoma in patients with chronic hepatitis B receiving entecavir.
|
Hepatology
|
2014
|
1.30
|
|
11
|
Polymorphisms near IL28B and serologic response to peginterferon in HBeAg-positive patients with chronic hepatitis B.
|
Gastroenterology
|
2011
|
1.28
|
|
12
|
Intrahepatic hepatitis B virus covalently closed circular DNA can be a predictor of sustained response to therapy.
|
Gastroenterology
|
2005
|
1.28
|
|
13
|
A cost comparison of management of chronic hepatitis B and its associated complications in Hong Kong and Singapore.
|
J Clin Gastroenterol
|
2004
|
1.15
|
|
14
|
Prediction of liver fibrosis and cirrhosis in chronic hepatitis B infection by serum proteomic fingerprinting: a pilot study.
|
Clin Chem
|
2004
|
1.14
|
|
15
|
Quantitative analysis of circulating methylated DNA as a biomarker for hepatocellular carcinoma.
|
Clin Chem
|
2008
|
1.13
|
|
16
|
Heme oxygenase-1 protects against steatohepatitis in both cultured hepatocytes and mice.
|
Gastroenterology
|
2009
|
1.13
|
|
17
|
Hepatitis B virus reactivation associated with anti-neoplastic therapy.
|
J Gastroenterol Hepatol
|
2013
|
1.07
|
|
18
|
Cyclooxygenase-2 pathway correlates with vascular endothelial growth factor expression and tumor angiogenesis in hepatitis B virus-associated hepatocellular carcinoma.
|
Int J Oncol
|
2004
|
1.06
|
|
19
|
Inhibitory role of peroxisome proliferator-activated receptor gamma in hepatocarcinogenesis in mice and in vitro.
|
Hepatology
|
2010
|
1.05
|
|
20
|
Expression of a cyclo-oxygenase-2 transgene in murine liver causes hepatitis.
|
Gut
|
2006
|
1.03
|
|
21
|
Chronic hepatitis B: whom to treat and for how long? Propositions, challenges, and future directions.
|
Hepatol Int
|
2010
|
1.03
|
|
22
|
52-week efficacy and safety of telbivudine with conditional tenofovir intensification at week 24 in HBeAg-positive chronic hepatitis B.
|
PLoS One
|
2013
|
1.01
|
|
23
|
COX-2 mediates hepatitis B virus X protein abrogation of p53-induced apoptosis.
|
Biochem Biophys Res Commun
|
2008
|
0.96
|
|
24
|
Genotype-specific genomic markers associated with primary hepatomas, based on complete genomic sequencing of hepatitis B virus.
|
J Virol
|
2008
|
0.95
|
|
25
|
Glucose-regulated protein 78 is an intracellular antiviral factor against hepatitis B virus.
|
Mol Cell Proteomics
|
2009
|
0.93
|
|
26
|
RNA interference targeting HBx suppresses tumor growth and enhances cisplatin chemosensitivity in human hepatocellular carcinoma.
|
Cancer Lett
|
2007
|
0.93
|
|
27
|
A1762T/G1764A mutations of hepatitis B virus, associated with the increased risk of hepatocellular carcinoma, reduce basal core promoter activities.
|
Biochem Biophys Res Commun
|
2008
|
0.92
|
|
28
|
An intensive surveillance program detected a high incidence of hepatocellular carcinoma among hepatitis B virus carriers with abnormal alpha-fetoprotein levels or abdominal ultrasonography results.
|
J Clin Oncol
|
2005
|
0.92
|
|
29
|
Elucidation of the role of COX-2 in liver fibrogenesis using transgenic mice.
|
Biochem Biophys Res Commun
|
2008
|
0.92
|
|
30
|
High-throughput quantitative profiling of serum N-glycome by MALDI-TOF mass spectrometry and N-glycomic fingerprint of liver fibrosis.
|
Clin Chem
|
2007
|
0.91
|
|
31
|
Moderate coffee consumption reduces the risk of hepatocellular carcinoma in hepatitis B chronic carriers: a case-control study.
|
J Epidemiol Community Health
|
2010
|
0.90
|
|
32
|
Transmission of hepatitis B by human bite--confirmation by detection of virus in saliva and full genome sequencing.
|
J Clin Virol
|
2005
|
0.90
|
|
33
|
Phyllanthus urinaria ameliorates the severity of nutritional steatohepatitis both in vitro and in vivo.
|
Hepatology
|
2008
|
0.89
|
|
34
|
Multiplex detection of 60 hepatitis B virus variants by maldi-tof mass spectrometry.
|
Clin Chem
|
2009
|
0.88
|
|
35
|
A magnetic bead-based serum proteomic fingerprinting method for parallel analytical analysis and micropreparative purification.
|
Electrophoresis
|
2010
|
0.86
|
|
36
|
Elevated perioperative transaminase level predicts intrahepatic recurrence in hepatitis B-related hepatocellular carcinoma after curative hepatectomy.
|
Asian J Surg
|
2008
|
0.86
|
|
37
|
Specific COX-2 inhibitor, NS-398, suppresses cellular proliferation and induces apoptosis in human hepatocellular carcinoma cells.
|
Int J Oncol
|
2003
|
0.85
|
|
38
|
Evaluation of model for end stage liver disease (MELD)-based systems as prognostic index for hepatocellular carcinoma.
|
J Gastroenterol Hepatol
|
2008
|
0.83
|
|
39
|
Use of antiviral therapy in surveillance: impact on outcome of hepatitis B-related hepatocellular carcinoma.
|
Liver Int
|
2011
|
0.81
|
|
40
|
Evaluation of histological staging systems for primary biliary cirrhosis: correlation with clinical and biochemical factors and significance of pathological parameters in prognostication.
|
Histopathology
|
2014
|
0.81
|
|
41
|
Aberrant concentrations of liver-derived plasma albumin mRNA in liver pathologies.
|
Clin Chem
|
2009
|
0.80
|
|
42
|
Retrospective analysis of liver function derangement in severe acute respiratory syndrome.
|
Am J Med
|
2004
|
0.79
|
|
43
|
Fatal outcome of SARS in a patient with reactivation of chronic hepatitis B.
|
Am J Med
|
2003
|
0.78
|
|
44
|
Lamivudine monoprophylaxis and adefovir salvage for liver transplantation in chronic hepatitis B: a seven-year follow-up study.
|
J Med Virol
|
2009
|
0.78
|
|
45
|
Treatment of chronic hepatitis B in Asia-Pacific countries: is the Asia-Pacific consensus statement being followed?
|
Antivir Ther
|
2010
|
0.78
|
|
46
|
A review of telbivudine for the management of chronic hepatitis B virus infection.
|
Expert Opin Drug Metab Toxicol
|
2008
|
0.77
|
|
47
|
Lipoprotein lipase activator ameliorates the severity of dietary steatohepatitis.
|
Biochem Biophys Res Commun
|
2007
|
0.77
|
|
48
|
Patient-reported Outcomes in Asian Patients With Chronic Hepatitis C Treated With Ledipasvir and Sofosbuvir.
|
Medicine (Baltimore)
|
2016
|
0.77
|
|
49
|
Revisiting the treatment recommendations for chronic hepatitis B.
|
Hepatology
|
2009
|
0.77
|
|
50
|
High level virion production and surface antigen expression with 1.5 copies of hepatitis B viral genome.
|
J Virol Methods
|
2009
|
0.76
|
|
51
|
Icteric flare of chronic hepatitis B in a 95-year old patient.
|
World J Gastroenterol
|
2003
|
0.75
|
|
52
|
Adoptive immune transfer in liver transplantation of HBV-related liver diseases.
|
Hepatology
|
2003
|
0.75
|
|
53
|
Quantitative subtyping of hepatitis B virus reveals complex dynamics of YMDD motif mutants development during long-term lamivudine therapy.
|
Antivir Ther
|
2006
|
0.75
|
|
54
|
Treatment of chronic hepatitis B: focus on telbivudine.
|
Expert Rev Anti Infect Ther
|
2009
|
0.75
|
|
55
|
Entecavir plus adefovir versus adefovir plus lamivudine in hepatitis B virus e antigen-positive, lamivudine-resistant chronic hepatitis B.
|
J Gastroenterol Hepatol
|
2014
|
0.75
|
|
56
|
Data mining on DNA sequences of hepatitis B virus.
|
IEEE/ACM Trans Comput Biol Bioinform
|
2011
|
0.75
|